Summary
50 / 100 · Bulios Score
What speaks for it
- Out of every 100 CNY of revenue, 15 CNY is left as net profit.
- Analysts expect revenue to grow by 104% this fiscal year.
What to watch
- Revenue fell by 18% a year over the last 3 years.
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 11.2 CNY for 1 CNY of yearly profit. Over the last five years it was 35.4 CNY on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (CNY)
Diluted EPS (CNY)
- Analyst estimate
Revenue grew by 33% a year over 5 years. Over the last 3 years it fell by 18% a year. For the next fiscal year analysts expect revenue to grow by 104%.
Growth in detailDoes it make money?
Very wellWhere 100 CNY of revenue goes
- Cost of sales 75 CNY
- Research and development 2.5 CNY
- Sales and administration 2.1 CNY
- Taxes and other 5.8 CNY
- Net profit 15 CNY
Net profit, industry median (Chemicals) 4.6 CNY
Out of every 100 CNY of revenue, 15 CNY is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 15.7 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
Small, safe- Yield
- 0.42%
- Paid out of profit
- 4.8%
You receive ¥0.15 per share a year. The company covers the payout with ease.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detail